Systematic review shows equivalent efficacy and superior safety of DOACs versus VKAs in cerebral venous thrombosis, indicating a better treatment option.
To perform the largest systematic review and meta-analysis comparing DOACs and VKAs in CVT, evaluating efficacy, safety, and treatment durability to date.
No takes yet. Share an insight, caveat, or question.
Zahoor et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: